Invivyd vs Pelthos Therapeutics
IVVD and PTHS side by side, both in drugs. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How IVVD and PTHS compare
Invivyd is the larger company, worth 5.8 times as much as Pelthos Therapeutics ($158M against $27.4M).
Invivyd keeps more of each dollar of sales as profit, with a net margin of −184% compared with −200% at Pelthos Therapeutics.
Invivyd scores higher on the StockData Score (9 against 2 for Pelthos Therapeutics), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | IVVD | PTHS |
|---|---|---|
| Size and price | ||
| Market cap | $158M | $27.4M |
| Share price | $0.538 | $7.15 |
| Change, 1 year | −69.6% | −79.4% |
| Change, 5 years | −97.9% | – |
| Beta (5Y) | 2.47 | 0.91 |
| Employees | 122 | 92 |
| StockData Score | ||
| Total score | 9 (better) | 2 |
| Valuation score | 3 (better) | 1 |
| Growth score | 1 (better) | 0 |
| Performance score | 0 | 0 |
| Health score | 5 (better) | 1 |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/S | 2.7× | 0.6× (better) |
| P/B | 0.9× | – |
| FCF yield | −69.2% | – |
| Fair value | $0.983 | – |
| Margin of safety | 45.3% | – |
| Growth | ||
| Revenue growth (TTM) | 26.3% | – |
| Profitability | ||
| Gross margin | – | 78.6% |
| Operating margin | −193% | −133% (better) |
| Net margin | −184% (better) | −200% |
| FCF margin | −188% | – |
| Return on equity | −95.9% | – |
| Return on invested capital | −616% | – |
| Financial health | ||
| Debt / equity | 0.00 | – |
| Interest coverage | – | −7.8× |
| Current ratio | 5.87 (better) | 1.98 |
| Altman Z-score | −4.74 | −1.83 (better) |
| Piotroski F-score | 5 | 5 |
| Dividends and buybacks | ||
| Buyback yield | −0.24% | – |
| Shareholder yield | −0.24% | 0.00% (better) |
| Ownership | ||
| Held by institutions | 79.0% | 35.6% |
| Held by insiders | 16.7% | – |
| Insider net buying, 12 months | −$531K | $794K (better) |
| Short interest, % of float | 14.7% | – |
Go deeper
- IVVD stock overview
- IVVD income statement
- IVVD valuation and score
- PTHS stock overview
- PTHS income statement
- PTHS valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.